Kinfo
Danaher Corp. logo

Danaher Corp.

DHRNYSEHealthcare·US · USD
$219.81
+2.35 (+1.08%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap154.52B USD
Enterprise value177.12B USD
Trailing P/E39.04
Forward P/E23.55
PEG ratio0.65
Price / sales6.13
Price / book2.93
Profitability
Gross margin57.64%
Operating margin19.78%
Profit margin15.95%
Return on assets3.95%
Return on equity7.61%
Income (TTM)
Revenue25.11B USD
Gross profit14.75B USD
EBITDA7.77B USD
Net income3.99B USD
Diluted EPS$5.61
Rev. growth (YoY)5.50%
Balance sheet
Total cash4.35B USD
Total debt27.86B USD
Debt / equity52.97
Current ratio1.65
Book value / share$74.81
Cash flow (TTM)
Operating cash flow6.63B USD
Levered free cash flow4.33B USD
Shares & price
Shares outstanding702.90M
Float625.85M
Held by institutions84.39%
Beta0.80
50-day MA$210.58
200-day MA$201.48
52-week high$242.80
52-week low$160.93
Dividends
Forward rate
$1.60
Yield
0.73%
Payout ratio
25.67%
Frequency
Quarterly
Recent payments
  • 2026-09-30$0.40
Earnings (EPS)
DateEst.ActualSurprise2026-09-304.084.40+7.84%2026-07-161.101.17+6.36%2026-06-25-0.14-0.16−14.29%
About Danaher Corp.

Danaher Corp. is a global science and technology company focused on biotechnology, life sciences, and diagnostics. The company develops and supplies mission-critical tools, consumables, instruments, software, and services used in research, bioprocessing, clinical testing, and laboratory workflows. Its current business is organized around Biotechnology, Life Sciences, and Diagnostics, with offerings that support areas such as biologics manufacturing, molecular and clinical diagnostics, genomics, and analytical instrumentation. Danaher serves customers across healthcare, research, and industrial settings, helping laboratories and life sciences organizations improve efficiency, precision, and productivity. Headquartered in Washington, D.C., Danaher operates through a portfolio of specialized operating companies that provide products and solutions for scientific discovery, disease detection, and the production of biologic therapies.

Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Rainer M. Blair
Employees
58,000
Headquarters
Washington, DC, United States

Frequently asked questions about Danaher Corp.